This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 25 Apr 2022  |  North America

    US Health Insurance Growth Opportunities

    Transitional Care Delivery Models and Payer Policies Redefining Stakeholders’ Future Growth Strategies

    The United States is the world’s largest healthcare market, spending over 18% of its GDP on healthcare. Therefore, it is important for healthcare stakeholders to understand how the US healthcare market functions, primarily its insurance system. The US health insurance landscape has seen significant evolution through various legislations, ranging ...

    $2,450.00
  2. 22 Apr 2022  |  Global

    Global Deep Brain Stimulation Growth Opportunities

    Exploration of New Clinical Applications Drive Future Growth Potential

    Deep brain stimulation (DBS) therapies target a growing number of existing indications, including movement disorders and neuropsychiatric conditions, and newer areas such as lifestyle disorders, including diabetes and obesity. This will allow more patients to benefit from the therapy. According to the WHO, neurological diseases currently contribute...

    $2,450.00
  3. 18 Apr 2022  |  North America

    Global Vaccine Growth Opportunities

    Capability Expansion in Nucleic Acid-based Vaccines is Accelerating the Disruption in Vaccines Globally

    Frost & Sullivan provides an outlook for the global vaccine industry for 2022 and beyond, including emerging trends and growth opportunities. Innovation, which remains mainstream in vaccine development, is augmenting investments by emerging vaccine developers in designing novel technology platforms, especially for nucleic acid-based vaccines. Spurr...

    $4,950.00
  4. 13 Apr 2022  |  North America

    US Life Sciences Research Tools Growth Opportunities

    Transformational Growth with the Proposed Launch of ARPA-H to Spur Investments across High-risk, High-reward Translational Research Projects, Foster Breakthroughs, and Facilitate Equitable Access to Care

    The US life sciences research tools market encompasses analytical tools, instruments, consumables, reagents, and services (e.g., X-rays and sample preparation). Tools include laboratory automation and technologies that provide molecular insight into disease mechanisms and enable novel therapeutic and medical device development to improve human heal...

    $2,450.00
  5. 01 Apr 2022  |  North America

    Global Medical Imaging and Informatics Outlook, 2022

    Smart Manufacturing and Cloud-based AI Solutions will Drive Market Growth and the Efficiency of Medical Imaging and Informatics

    The global medical imaging and informatics market is experiencing significant changes with the emergence of advanced technologies, the changing consumer landscape and priorities, consolidation among radiology practices, mergers and acquisitions, portability, regulatory and reimbursement changes, smart manufacturing, local and global manufacturing, ...

    $4,950.00
  6. 31 Mar 2022  |  North America

    US Ambulatory Surgery Centers Growth Opportunities

    Future Growth Potential of Ambulatory Surgery Centers Increases Opportunities for Medtech

    The shift of surgery volumes from inpatient to outpatient has been ongoing for a while, owing to lower costs. While several procedures are done in outpatient settings, public and private payers in the US push for ambulatory surgery centers (ASCs) to conduct these procedures in outpatient settings than in hospital outpatient departments (HOPDs), as ...

    $2,450.00
  7. 29 Mar 2022  |  Global

    Global Ultraviolet-C (UVC) Disinfectant Equipment Growth Opportunities

    Automated Robots are Empowering the Future Growth Of UVC Disinfectant Equipment

    The UVC disinfectant equipment market is expected to witness significant growth over the next 3-5 years, driven by the increased focus on infection control due to the COVID-19 pandemic, the expanding application areas, and the effectiveness of disinfection using UVC when compared to other methods. This Frost & Sullivan study provides information...

    $2,450.00
  8. 29 Mar 2022  |  North America

    US RCM Growth Opportunities

    Internal Challenges due to COVID-19 Accelerated the Shift to Revenue Cycle Management (RCM) Outsourcing

    This research service provides an overview of the US revenue cycle management, revenue forecast, and competitive analysis of various legacy and modular RCM solutions. This study explores RCM applications across front-end, middle, and back-end processes and the end users are hospitals and ambulatory physician practices. In addition, it offers detail...

    $4,950.00
  9. 23 Mar 2022  |  North America

    Global Digital Health Outlook, 2022

    Innovative Business Models of Remote Patient Monitoring Solutions Go beyond Chronic Care Management and Across the Care Continuum

    Digital health offered extensive support and grew stronger as the pandemic continued with several variants across the globe. Telehealth and other enterprise IT solutions continued to be the backbone for healthcare systems, and access to health in the hands of the patients empowered consumers to manage their health with the best of tools. As the dem...

    $4,950.00
  10. 14 Mar 2022  |  North America

    Next-generation Diagnostics Outlook, 2022

    Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth

    In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...

    $4,950.00